A Safety and Pharmacokinetic Study Between HLX02 and Herceptin®(US-licensed and EU-approved) in Healthy Chinese Male Subjects
Clinical trial NCT04670796 · COMPLETED
Trial details
- NCT number
- NCT04670796
- Sponsor
- Shanghai Henlius Biotech
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-02
- Primary completion
- 2021-06-04
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.